Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1983 Aug;48(2):209–215. doi: 10.1038/bjc.1983.176

Atopy--a favourable prognostic factor for survival in Hodgkin's disease.

P L Amlot, J Slaney, R Brown
PMCID: PMC2011439  PMID: 6882661

Abstract

One hundred and forty-eight patients with Hodgkin's disease (HD) were stratified into 4 groups according to atopic status. Group 1 had a personal history of atopy and Group 2 a family history of atopy. In Groups 3 and 4 there was no history of atopy but high serum IgE levels (Group 3) and normal IgE levels (Group 4). Comparison of the survival of these groups by the logrank method showed a significant trend (P = less than 0.0001) where survival was ranked Group 1 greater than 2 greater than 3 greater than 4. Known prognostic factors in HD--age, sex, stage, symptoms and histology--had to be taken into account, since their distribution differed between the atopic groups. In Group I there was more stage IA and IIA disease and less "B" symptoms, in Group 3 more nodular sclerosis histology and more "B" symptoms and in Group 4 more lymphocyte-depleted histology and a higher mean age than expected from their distribution in the combined groups. Adjustment to allow for the variation in each of the other prognostic factors and for a combination of age, symptoms and histology still showed a significant trend of survival on the basis of atopic status. The increased survival of atopic patients suggests that atopic mechanisms or the genetic basis to atopy has a protective effect in HD either directly or by interaction with treatment.

Full text

PDF
209

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amlot P. L., Green L. A. Atopy and immunoglobulin E concentrations in Hodgkin's disease and other lymphomas. Br Med J. 1978 Feb 11;1(6109):327–329. doi: 10.1136/bmj.1.6109.327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Amlot P. L., Slaney J. Hypergammaglobulinaemia E in HOdgkin's disease and its relationship to atopy or a familial predisposition to atopy. Int Arch Allergy Appl Immunol. 1981;64(2):138–145. doi: 10.1159/000232685. [DOI] [PubMed] [Google Scholar]
  3. Axtell L. M., Myers M. H., Thomas L. H., Berard C. W., Kagan A. R., Newell G. R. Prognostic indicators in Hodgkin's disease. Cancer. 1972 Jun;29(6):1481–1488. doi: 10.1002/1097-0142(197206)29:6<1481::aid-cncr2820290611>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  4. Bartholomaeus W. N., Keast D. Reaginic antibody to tumour and alloantigens in mice. Nat New Biol. 1972 Oct 18;239(94):206–207. doi: 10.1038/newbio239206a0. [DOI] [PubMed] [Google Scholar]
  5. Broom B. C., Alexander P. Rat tumour allografts evoke anaphylactic antibody responses. Immunology. 1975 Jun;28(6):1033–1040. [PMC free article] [PubMed] [Google Scholar]
  6. Carbone P. P., Kaplan H. S., Musshoff K., Smithers D. W., Tubiana M. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res. 1971 Nov;31(11):1860–1861. [PubMed] [Google Scholar]
  7. Coppleson L. W., Rappaport H., Strum S. B., Rose J. Analysis of the Rye classification of Hodgkin's disease. The prognostic significance of cellular composition. J Natl Cancer Inst. 1973 Aug;51(2):379–390. [PubMed] [Google Scholar]
  8. DWORIN M., DIAMOND H. D., CRAVER L. F. Hodgkin's disease and allergy. Cancer. 1955 Jan-Feb;8(1):128–131. doi: 10.1002/1097-0142(1955)8:1<128::aid-cncr2820080117>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  9. Devita V. T., Jr, Serpick A. A., Carbone P. P. Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med. 1970 Dec;73(6):881–895. doi: 10.7326/0003-4819-73-6-881. [DOI] [PubMed] [Google Scholar]
  10. Dvorak H. F., Dvorak A. M., Churchill W. H. Immunologic rejection of diethylnitrosamine-induced hepatomas in strain 2 guinea pigs: participation of basophilic leukocytes and macrophage aggregates. J Exp Med. 1973 Mar 1;137(3):751–775. doi: 10.1084/jem.137.3.751. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. FISHERMAN E. W. Does the allergic diathesis influence malignancy? J Allergy. 1960 Jan-Feb;31:74–78. doi: 10.1016/0021-8707(60)90026-5. [DOI] [PubMed] [Google Scholar]
  12. Kaplan H. S., Rosenberg S. A. The management of Hodgkin's disease. Cancer. 1975 Aug;36(2):796–803. doi: 10.1002/1097-0142(197508)36:2+<796::aid-cncr2820360825>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  13. Likhite V. V. The delayed and lasting rejection of mammary adenocarcinoma cell tumors in DBA-2 mice with use of killed Bordetella pertussis. Cancer Res. 1974 May;34(5):1027–1030. [PubMed] [Google Scholar]
  14. Lokich J. J., Pinkus G. S., Moloney W. C. Hodgkin's disease in the elderly. Oncology. 1974;29(6):484–500. doi: 10.1159/000224931. [DOI] [PubMed] [Google Scholar]
  15. Lukes R. J., Butler J. J. The pathology and nomenclature of Hodgkin's disease. Cancer Res. 1966 Jun;26(6):1063–1083. [PubMed] [Google Scholar]
  16. Mackay W. D. The incidence of allergic disorders and cancer. Br J Cancer. 1966 Sep;20(3):434–437. doi: 10.1038/bjc.1966.52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. McCormick D. P., Ammann A. J., Ishizaka K., Miller D. G., Hong R. A study of allergy in patients with malignant lymphoma and chronic lymphocytic leukemia. Cancer. 1971 Jan;27(1):93–99. doi: 10.1002/1097-0142(197101)27:1<93::aid-cncr2820270114>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  18. Ogilvie B. M., Jones V. E. Immunity in the parasitic relationship between helminths and hosts. Prog Allergy. 1973;17:93–144. [PubMed] [Google Scholar]
  19. Ogilvie B. M., Simpson E., Keller R. Tumour growth in nematode-infected animals. Lancet. 1971 Apr 3;1(7701):678–680. doi: 10.1016/s0140-6736(71)92683-3. [DOI] [PubMed] [Google Scholar]
  20. Perry L. L., Benacerraf B., McCluskey R. T., Greene M. I. Enhanced syngeneic tumor destruction by in vivo inhibition of suppressor T cells using anti-I-J alloantiserum. Am J Pathol. 1978 Aug;92(2):491–506. [PMC free article] [PubMed] [Google Scholar]
  21. Shapiro S., Heinonen O. P., Siskind V. Cancer and allergy. Cancer. 1971 Aug;28(2):396–400. doi: 10.1002/1097-0142(197108)28:2<396::aid-cncr2820280220>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  22. Tilkin A. F., Schaaf-Lafontaine N., Van Acker A., Boccadoro M., Urbain J. Reduced tumor growth after low-dose irradiation or immunization against blastic suppressor T cells. Proc Natl Acad Sci U S A. 1981 Mar;78(3):1809–1812. doi: 10.1073/pnas.78.3.1809. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Waldmann T. A., Bull J. M., Bruce R. M., Broder S., Jost M. C., Balestra S. T., Suer M. E. Serum immunoglobulin E levels in patients with neoplastic disease. J Immunol. 1974 Jul;113(1):379–386. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES